<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang xml:lang>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Your Digest for Wednesday, Nov 01, 2023 11:59 PM</title>
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    span.underline{text-decoration: underline;}
    div.column{display: inline-block; vertical-align: top; width: 50%;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
  </style>
  <style type="text/css">
:root,
::backdrop {

--sans-font: -apple-system, BlinkMacSystemFont, "Avenir Next", Avenir,
"Nimbus Sans L", Roboto, "Noto Sans", "Segoe UI", Arial, Helvetica,
"Helvetica Neue", sans-serif;
--mono-font: Consolas, Menlo, Monaco, "Andale Mono", "Ubuntu Mono", monospace;
--standard-border-radius: 5px;

--bg: #fff;
--accent-bg: #f5f7ff;
--text: #212121;
--text-light: #585858;
--border: #898EA4;
--accent: #0d47a1;
--code: #d81b60;
--preformatted: #444;
--marked: #ffdd33;
--disabled: #efefef;
}

@media (prefers-color-scheme: dark) {
:root,
::backdrop {
color-scheme: dark;
--bg: #212121;
--accent-bg: #2b2b2b;
--text: #dcdcdc;
--text-light: #ababab;
--accent: #ffb300;
--code: #f06292;
--preformatted: #ccc;
--disabled: #111;
}

img,
video {
opacity: 0.8;
}
}

*, *::before, *::after {
box-sizing: border-box;
}

textarea,
select,
input,
progress {
appearance: none;
-webkit-appearance: none;
-moz-appearance: none;
}
html {

font-family: var(--sans-font);
scroll-behavior: smooth;
}

body {
color: var(--text);
background-color: var(--bg);
font-size: 1.15rem;
line-height: 1.5;
display: grid;
grid-template-columns: 1fr min(45rem, 90%) 1fr;
margin: 0;
}
body > * {
grid-column: 2;
}

body > header {
background-color: var(--accent-bg);
border-bottom: 1px solid var(--border);
text-align: center;
padding: 0 0.5rem 2rem 0.5rem;
grid-column: 1 / -1;
}
body > header h1 {
max-width: 1200px;
margin: 1rem auto;
}
body > header p {
max-width: 40rem;
margin: 1rem auto;
}

main {
padding-top: 1.5rem;
}
body > footer {
margin-top: 4rem;
padding: 2rem 1rem 1.5rem 1rem;
color: var(--text-light);
font-size: 0.9rem;
text-align: center;
border-top: 1px solid var(--border);
}

h1 {
font-size: 3rem;
}
h2 {
font-size: 2.6rem;
margin-top: 3rem;
}
h3 {
font-size: 2rem;
margin-top: 3rem;
}
h4 {
font-size: 1.44rem;
}
h5 {
font-size: 1.15rem;
}
h6 {
font-size: 0.96rem;
}

p, h1, h2, h3, h4, h5, h6 {
overflow-wrap: break-word;
}

h1,
h2,
h3 {
line-height: 1.1;
}

@media only screen and (max-width: 720px) {
h1 {
font-size: 2.5rem;
}
h2 {
font-size: 2.1rem;
}
h3 {
font-size: 1.75rem;
}
h4 {
font-size: 1.25rem;
}
}

a,
a:visited {
color: var(--accent);
}
a:hover {
text-decoration: none;
}
button,
.button,
a.button, 
input[type="submit"],
input[type="reset"],
input[type="button"],
label[type="button"] {
border: none;
border-radius: var(--standard-border-radius);
background-color: var(--accent);
font-size: 1rem;
color: var(--bg);
padding: 0.7rem 0.9rem;
margin: 0.5rem 0;
text-decoration: none;
font-family: inherit;
line-height: normal;
}
.button[aria-disabled="true"], input:disabled,
textarea:disabled,
select:disabled,
button[disabled] {
cursor: not-allowed;
background-color: var(--disabled);
color: var(--text-light)
}
input[type="range"] {
padding: 0;
}

abbr[title] {
cursor: help;
text-decoration-line: underline;
text-decoration-style: dotted;
}
button:enabled:hover,
.button:not([aria-disabled="true"]):hover,
input[type="submit"]:enabled:hover,
input[type="reset"]:enabled:hover,
input[type="button"]:enabled:hover,
label[type="button"]:hover {
filter: brightness(1.4);
cursor: pointer;
}
.button:focus-visible,
button:focus-visible:where(:enabled),
input:enabled:focus-visible:where(
[type="submit"],
[type="reset"],
[type="button"]
) {
outline: 2px solid var(--accent);
outline-offset: 1px;
}

header > nav {
font-size: 1rem;
line-height: 2;
padding: 1rem 0 0 0;
}

header > nav ul,
header > nav ol {
align-content: space-around;
align-items: center;
display: flex;
flex-direction: row;
flex-wrap: wrap;
justify-content: center;
list-style-type: none;
margin: 0;
padding: 0;
}

header > nav ul li,
header > nav ol li {
display: inline-block;
}
header > nav a,
header > nav a:visited {
margin: 0 0.5rem 1rem 0.5rem;
border: 1px solid var(--border);
border-radius: var(--standard-border-radius);
color: var(--text);
display: inline-block;
padding: 0.1rem 1rem;
text-decoration: none;
}
header > nav a:hover,
header > nav a.current,
header > nav a[aria-current="page"] {
border-color: var(--accent);
color: var(--accent);
cursor: pointer;
}

@media only screen and (max-width: 720px) {
header > nav a {
border: none;
padding: 0;
text-decoration: underline;
line-height: 1;
}
}

aside, details, pre, progress {
background-color: var(--accent-bg);
border: 1px solid var(--border);
border-radius: var(--standard-border-radius);
margin-bottom: 1rem;
}
aside {
font-size: 1rem;
width: 30%;
padding: 0 15px;
margin-inline-start: 15px;
float: right;
}
*[dir="rtl"] aside {
float: left;
}

@media only screen and (max-width: 720px) {
aside {
width: 100%;
float: none;
margin-inline-start: 0;
}
}
article, fieldset, dialog {
border: 1px solid var(--border);
padding: 1rem;
border-radius: var(--standard-border-radius);
margin-bottom: 1rem;
}
article h2:first-child,
section h2:first-child {
margin-top: 1rem;
}
section {
border-top: 1px solid var(--border);
border-bottom: 1px solid var(--border);
padding: 2rem 1rem;
margin: 3rem 0;
}

section + section,
section:first-child {
border-top: 0;
padding-top: 0;
}
section:last-child {
border-bottom: 0;
padding-bottom: 0;
}
details {
padding: 0.7rem 1rem;
}
summary {
cursor: pointer;
font-weight: bold;
padding: 0.7rem 1rem;
margin: -0.7rem -1rem;
word-break: break-all;
}
details[open] > summary + * {
margin-top: 0;
}
details[open] > summary {
margin-bottom: 0.5rem;
}
details[open] > :last-child {
margin-bottom: 0;
}

table {
border-collapse: collapse;
margin: 1.5rem 0;
}
td,
th {
border: 1px solid var(--border);
text-align: start;
padding: 0.5rem;
}
th {
background-color: var(--accent-bg);
font-weight: bold;
}
tr:nth-child(even) {

background-color: var(--accent-bg);
}
table caption {
font-weight: bold;
margin-bottom: 0.5rem;
}

textarea,
select,
input {
font-size: inherit;
font-family: inherit;
padding: 0.5rem;
margin-bottom: 0.5rem;
color: var(--text);
background-color: var(--bg);
border: 1px solid var(--border);
border-radius: var(--standard-border-radius);
box-shadow: none;
max-width: 100%;
display: inline-block;
}
label {
display: block;
}
textarea:not([cols]) {
width: 100%;
}

select:not([multiple]) {
background-image: linear-gradient(45deg, transparent 49%, var(--text) 51%),
linear-gradient(135deg, var(--text) 51%, transparent 49%);
background-position: calc(100% - 15px), calc(100% - 10px);
background-size: 5px 5px, 5px 5px;
background-repeat: no-repeat;
padding-inline-end: 25px;
}
*[dir="rtl"] select:not([multiple]) {
background-position: 10px, 15px;
}

input[type="checkbox"],
input[type="radio"] {
vertical-align: middle;
position: relative;
width: min-content;
}
input[type="checkbox"] + label,
input[type="radio"] + label {
display: inline-block;
}
input[type="radio"] {
border-radius: 100%;
}
input[type="checkbox"]:checked,
input[type="radio"]:checked {
background-color: var(--accent);
}
input[type="checkbox"]:checked::after {

content: " ";
width: 0.18em;
height: 0.32em;
border-radius: 0;
position: absolute;
top: 0.05em;
left: 0.17em;
background-color: transparent;
border-right: solid var(--bg) 0.08em;
border-bottom: solid var(--bg) 0.08em;
font-size: 1.8em;
transform: rotate(45deg);
}
input[type="radio"]:checked::after {

content: " ";
width: 0.25em;
height: 0.25em;
border-radius: 100%;
position: absolute;
top: 0.125em;
background-color: var(--bg);
left: 0.125em;
font-size: 32px;
}

@media only screen and (max-width: 720px) {
textarea,
select,
input {
width: 100%;
}
}

input[type="color"] {
height: 2.5rem;
padding: 0.2rem;
}

input[type="file"] {
border: 0;
}

hr {
border: none;
height: 1px;
background: var(--border);
margin: 1rem auto;
}
mark {
padding: 2px 5px;
border-radius: var(--standard-border-radius);
background-color: var(--marked);
color: black;
}
img,
video {
max-width: 100%;
height: auto;
border-radius: var(--standard-border-radius);
}
figure {
margin: 0;
display: block;
overflow-x: auto;
}
figcaption {
text-align: center;
font-size: 0.9rem;
color: var(--text-light);
margin-bottom: 1rem;
}
blockquote {
margin-inline-start: 2rem;
margin-inline-end: 0;
margin-block: 2rem;
padding: 0.4rem 0.8rem;
border-inline-start: 0.35rem solid var(--accent);
color: var(--text-light);
font-style: italic;
}
cite {
font-size: 0.9rem;
color: var(--text-light);
font-style: normal;
}
dt {
color: var(--text-light);
}

code,
pre,
pre span,
kbd,
samp {
font-family: var(--mono-font);
color: var(--code);
}
kbd {
color: var(--preformatted);
border: 1px solid var(--preformatted);
border-bottom: 3px solid var(--preformatted);
border-radius: var(--standard-border-radius);
padding: 0.1rem 0.4rem;
}
pre {
padding: 1rem 1.4rem;
max-width: 100%;
overflow: auto;
color: var(--preformatted);
}

pre code {
color: var(--preformatted);
background: none;
margin: 0;
padding: 0;
}



progress {
width: 100%;
}
progress:indeterminate {
background-color: var(--accent-bg);
}
progress::-webkit-progress-bar {
border-radius: var(--standard-border-radius);
background-color: var(--accent-bg);
}
progress::-webkit-progress-value {
border-radius: var(--standard-border-radius);
background-color: var(--accent);
}
progress::-moz-progress-bar {
border-radius: var(--standard-border-radius);
background-color: var(--accent);
transition-property: width;
transition-duration: 0.3s;
}
progress:indeterminate::-moz-progress-bar {
background-color: var(--accent-bg);
}
dialog {
max-width: 40rem;
margin: auto;
}
dialog::backdrop {
background-color: var(--bg);
opacity: 0.8;
}
@media only screen and (max-width: 720px) {
dialog {
max-width: 100%;
margin: auto 1em;
}
}

.notice {
background: var(--accent-bg);
border: 2px solid var(--border);
border-radius: 5px;
padding: 1.5rem;
margin: 2rem 0;
}

strong{
color:#d81b60;
}
em {
color:#e0467e; 
}
hr
{
border: 1px;
clear: both;
display: block;
width: 100%;
height: 1px;

background-color:#686868
}
</style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">Your Digest for Wednesday, Nov 01, 2023 11:59 PM</h1>
</header>
<hr />
<p>#2022GM-MAY/Q27</p>
<hr />
<p>Main route is <strong>percutaneous inoculation</strong>. <em>Inhalation</em> and <em>ingestion</em> also possible.<br />
Tranmission <em>may</em> be through the <strong>inhaled</strong> route as well.<br />
<em>Person to person transmission is extremely rare</em>.</p>
<ul>
<li><strong>Alcohol</strong> abuse</li>
<li>Chronic <strong>kidney</strong> disease</li>
<li>chronic <strong>lung</strong> disease</li>
</ul>
<blockquote>
<p>[!TIP] Mnemonic: The usual rural farmer who drink and smokes and has kidney disease<br />
<strong>Culture</strong>: <strong>Gold standard</strong>. Grows on usual types of agar; Resistant to <em>gentamicin</em>. To <strong>gentamicin</strong> based cultures can selectively grow <em>Burkholderia</em><br />
Apparently <em>serology is unreliable.</em> (UpToDate)</p>
</blockquote>
<hr />
<p>Target INR is between <strong>2 - 3</strong></p>
<hr />
<p>Direct Coombs test and <strong>cold-agglutinin</strong> titers are typically positive</p>
<blockquote>
<p><strong>Directed treatment of</strong> <strong><em>M. pneumonia</em></strong> − For patients with microbiologically confirmed <em>M. pneumoniae</em> pneumonia, first-line treatment options include <strong>macrolides</strong> (eg, <a href="https://www.uptodate.com/contents/azithromycin-drug-information?search=mycoplasma%20pneumonia&amp;topicRef=6989&amp;source=see_link">azithromycin</a>), <em>tetracyclines</em> (eg, <a href="https://www.uptodate.com/contents/doxycycline-drug-information?search=mycoplasma%20pneumonia&amp;topicRef=6989&amp;source=see_link">doxycycline</a>), and respiratory <em>fluoroquinolones</em> (eg, <a href="https://www.uptodate.com/contents/levofloxacin-drug-information?search=mycoplasma%20pneumonia&amp;topicRef=6989&amp;source=see_link">levofloxacin</a> or <a href="https://www.uptodate.com/contents/moxifloxacin-drug-information?search=mycoplasma%20pneumonia&amp;topicRef=6989&amp;source=see_link">moxifloxacin</a>).<br />
Diagnosis is by culture of stool on selective media. (<strong>peptone alkaline media</strong> etc. ) Clinical diagnosis is usually possible.<br />
<em>Antibiotics shorten disease duration</em> : <em>macrolides</em>, <em>fluoroquinolones</em> and tetracyclines.</p>
</blockquote>
<ul>
<li>Salmonella typhi 👌🏼survive gastric juice and penetrate the <em>small bowel</em> epithelium <em>and disseminate</em> through the lymphoid tissue and blood vessels.</li>
<li>📑Epithelium -&gt; <strong>Peyer&#39;s patches</strong> (<em>causing HYPERTROPHY of Peyer&#39;s patches</em>) -&gt; RET via lymph and blood -&gt; Eventually, organisms reside <strong>👌🏼within tissue macrophages</strong> in the <strong>👌🏼liver, spleen, and bone marrow</strong>.</li>
<li><strong>Necrosis</strong> of submucosal tissues -&gt; abdominal pain and possible <strong>ileal perforation</strong>.<br />
Rose spots are <em>❗non tender</em>, <em>blanching papules</em>. - <em>occurs in 2nd week</em>.</li>
</ul>
<ol>
<li><em>Chronic carrier state</em> - <em>minority of cases only.</em><br />
2. Commoner in <em>females and those with biliary problems</em> like cholelithiasis.</li>
</ol>
<ul>
<li>To be given to people in high risk areas <em>(jaffna, mullativu, puttalam, nuwara eliya)</em> and high risk occupations (<em>food handler, HCW in contact with tyhpoid patients etc.</em>)</li>
</ul>
<h1 id="nontyphoidal-salmonella">👌🏼Nontyphoidal salmonella</h1>
<pre><code>- Infants, and those aged &gt; 60 are at higher risk of severe disease.
- *However, usually self limited*.
- **Diagnosis** *requires stool culture*.
    - When indicated, use *fluorquinolone* for 1 to 2 weeks.
    - Intestinal infection can progress to infect any site. *Urinary infection* is the commonest. (i.e long bones, visceral etc)
</code></pre>
<p>Few progress to <strong>fulminant hepatic failur</strong>e -&gt; poor prognosis.</p>
<p><img src="data:image/jpeg;base64,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" alt="radarMeaslesMnemonic.jpg" /><br />
#2021BSQ-NOV/Q37<br />
Subacute sclerosing panencephalitis (symptoms occur due to <em>viral reactivation in teenage years</em>) and post measles encephalomyeltis (2 weeks after infection) are dreaded complications.<br />
Acute infection can present with &quot;swimmer&#39;s itch&quot; (acute itch after swimming + localized dermatitis - <em>when parasite enters the skin</em>) and/or acute schistosomiasis syndrome (<em>Katayama syndrome</em>), a systemic <strong>hypersensitivity</strong> reaction to schistosome antigens and circulating immune complexes. (See <a href="https://www.uptodate.com/contents/schistosomiasis-epidemiology-and-clinical-manifestations?search=schistosomiasis&amp;source=search_result&amp;selectedTitle=1~89&amp;usage_type=default&amp;display_rank=1#H6283786">&#39;Acute infection&#39;</a> above.)<br />
<strong>Treatment:</strong> <em>Praziquantel</em> - antihelminthic drug and steroids to reduce inflammation.</p>
<hr />
<blockquote>
<pre><code>  - Common Side effect of levodopa and dopamine agonists. Can be due to *inadequate* DDC inhibitor. *Treat with domperidone* but *avoid metoclopramide* which is a *dopamine antagonist*. Early side effect. Settles with time.
</code></pre>
<ul>
<li>Confusion / <em>hallucinations</em><br />
<strong>Deep brain stimulation</strong> is specially useful for severe motor symptoms not responding to medicine. (specially in patients with youger onset of disease). Improves diskinesia, <em>seems as effective as levodopa</em>. Trend is towards earlier use before motor symptoms become severe.</li>
</ul>
</blockquote>
<h1 id="q-12-csf-analysis">👌🏼Q 12: CSF analysis</h1>
<hr />
<pre><code>- Degeneration of *frontal lobe motor* neurons and the *corticospinal tract* -&gt; Cause the **Upper motor nerve lesions** -&gt; present as *slowness and stiffness* with not much weakness.
- LMN signs are caused by degeneration of the *lower motor neurons* in the spinal cord -&gt; cause *weakness and atrophy.* 
        - upper motor signs like increased jaw jerk, lower motor signs like weakness of *muscles of mastication,* muscles of *facial expression* (incomplete eye closure) and *muscles of the pharynx and tongue* (*dysphagia, dysarthria*, poor palatal elevation)
        - Upper motor *👌🏼 decreased abdominal reflexes*; lower motor : abdominal protruberance, increased lumbar lordosis, difficulty holding head up and difficulty maintain erect posture. 
</code></pre>
<ul>
<li><strong>👌🏼Quickly</strong> and <strong>👌🏼relentlessly</strong> progressing: <em>death in about 5 years</em> &lt;- neuromuscular respiratory failure</li>
<li><strong>👌🏼Ataxia is not a feature</strong></li>
<li><em>Extra pyramidal features</em> can mimic Parkinson&#39;s - <em>👌🏼tremor, bradykinesia</em>; may precede or follow motor signs.</li>
<li><strong>❗No objective sensory losses.</strong>
<ul>
<li><strong>cognitive impairment</strong> &lt;- <em>frontotemporal dysfunction</em>; ALS is associated with <strong>frontotemporal dementia</strong> in upto 50% of cases.</li>
</ul></li>
<li>Disease modifying treatment: <em>Some drugs are available which prolong survival</em> and increase the time to requirement for tracheostomy and assisted ventilation. (See &#39;Riluzole&#39; and &#39;Edaravone&#39; and &#39;Sodium phenylbutyrate-taurursodiol&#39;) -&gt; <em>life expectance is increased by 3-4 months</em> on average.</li>
</ul>
<hr />
<h1 id="weber-syndrome">👌🏼Weber syndrome</h1>
<ul>
<li>CN III palsy with</li>
</ul>
<h1 id="alzheimers-disease">👌🏼Alzheimers disease</h1>
<p>Transmembrane protein &quot;<em>Amyloid precursor protein</em>&quot; (APP) is broken down by two pathways.<br />
? similar to lewy body dementia but <em>motor symptoms predominate</em>.<br />
type II pneumocytes are <em>more resistant to injury</em> but damage to them results in loss of surfactant and alveolar collapse.</p>
<ul>
<li>Overdistended alveoli undergo <strong>volutrauma</strong>.</li>
<li>The collapsed alveoli undergo cycles of collapse and expansion leading to <em>atelectrauma</em>. (i.e ARDS is an inhomogenous process)</li>
<li><em>Burns</em></li>
<li><em>Massive</em> transfusion</li>
</ul>
<hr />
<h1 id="types-of-systolic-murmurs">Types of systolic murmurs</h1>
<p>Late systolic - mitral valve prolapse.</p>
<hr />
<p>#2023GM-MAY/Q14</p>
<ol start="11">
<li>Pancreatitis</li>
</ol>
<blockquote>
<p>The majority of patients with an acute MI will have elevation in troponins within <strong>2 to 3 hours</strong> of arrival at the emergency department, versus 6 to 12 hours with creatine kinase.<a href="https://www.ncbi.nlm.nih.gov/books/NBK545216/">Source</a></p>
</blockquote>
<hr />
<ul>
<li><strong>Histology:</strong> Cellular infiltrates of <em>CD4+ cells</em>, macrophages and giant cells.</li>
<li>Patient has usually had <strong>past or current PMR</strong>. (<em>age always &gt; 50</em>)</li>
<li>Giving <strong>steroids is ESSENTIAL</strong>, since it can prevent vision loss due to <em>ophthalmic artery ischemia</em>.<br />
(eg, bruit, especially carotid; blood pressure difference of extremities, difference in <em>pulse volume, claudication</em>, hypertension)<br />
<em>Steroids</em> are the mainstay.<br />
Diagnosis: MR <em>angiograms</em>.</li>
</ul>
<blockquote>
<p><em>Characteristically</em>, <em>all stages of inflammation are present in different vessels</em> / same vessel.<br />
1/3 of patients have <em>chronic hepatitis B infection</em>.<br />
Probably <em>immune complex mediated</em> (as it&#39;s sometimes associated Hep B).</p>
</blockquote>
<ol start="8">
<li><em>Mononeuritis mulitiplex</em> - vaso vasorum infarctions<br />
Treatment: <em>Corticosteroids</em> +/- azathioprine.</li>
</ol>
<ul>
<li><em><strong>Steroids to now show benefit!</strong></em></li>
<li>Single dose of <em>Iv-Ig</em> followed by aspirin.</li>
</ul>
<blockquote>
<p>Of vasculitidies, small vessel vasculitides commonly <strong>affect the lungs.</strong><br />
<del>Small vessel vasculitides are <strong>ANCA</strong> positive.</del><br />
Frequent kidney involvement<br />
Fortunately for us, MPA and GPA are similar diseases but with some differences.<br />
URT - Otitis (<em>even hearing loss</em>), <strong>bloody nasal discharge</strong>, crusting, oral or nasal ulcers.<br />
<strong>Kidney</strong> - <strong>rapidly proliferative <em>glomerulonephritis</em></strong>. -&gt; <em><strong>nephritic</strong></em> picture<br />
Upper respiratory tract : <em>sinusitis</em> , ears -&gt; <em>Otitis</em> media.<br />
<em>Eosinophilia</em>+</p>
</blockquote>
</body>
</html>
